Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging agents and regimens for AML
Hongtao Liu
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 192

Showing 1-25 of 192 citing articles:

METTL1 mediated tRNA m7G modification promotes leukaemogenesis of AML via tRNA regulated translational control
Pan Zhao, Xia Lin, Dan Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Unveiling the potential of CLL-1: a promising target for AML therapy
Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Hamideh Rahmani Seraji, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia
Xiaoyan Hu, Lin Li, Jewel Nkwocha, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4
Mingying Li, Jingjing Ye, Xia Yuan, et al.
Leukemia (2022) Vol. 36, Iss. 11, pp. 2586-2595
Open Access | Times Cited: 51
Targeting IGF2BP3 in Cancer
Xin Liu, Jiayu Chen, Wenliang Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9423-9423
Open Access | Times Cited: 29
Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity
Yihong Wei, Wancheng Liu, Ruiqing Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 213, pp. 36-51
Closed Access | Times Cited: 14
Rational Design of a Novel Class of Human ClpP Agonists through a Ring-Opening Strategy with Enhanced Antileukemia Activity
Xinrong Xiang, Zhengyi Dai, Baozhu Luo, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6769-6792
Closed Access | Times Cited: 10
CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2/HO-1 axis, regulating CD8 + T cell response
Q. Cen, Jianyu Chen, Jiaxin Guo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Longer survival with precision medicine in late-stage cancer patients
Christophe K. Mapendano, Anne Krogh Nøhr, Mads Sønderkær, et al.
ESMO Open (2025) Vol. 10, Iss. 1, pp. 104089-104089
Open Access | Times Cited: 1
The Antitumor Effects and Apoptotic Mechanism of 20(S)-Protopanaxadiol in Acute Myeloid Leukemia
Ye Zhang, Saisai Ma, Yichen Xu, et al.
Journal of Ginseng Research (2025)
Open Access | Times Cited: 1
GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT
Dongyao Wang, Zimin Sun, Xiaoyu Zhu, et al.
Blood (2022) Vol. 140, Iss. 26, pp. 2788-2804
Open Access | Times Cited: 38
New drug approvals for 2022: Synthesis and clinical applications
Shuo Yuan, Dandan Shen, Rui Jia, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 2352-2391
Closed Access | Times Cited: 18
Valproic acid increases CAR T cell cytotoxicity against acute myeloid leukemia
Jingjing Wen, Yanxin Chen, Jiajie Yang, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 7, pp. e006857-e006857
Open Access | Times Cited: 18
Immunotherapies of acute myeloid leukemia: Rationale, clinical evidence and perspective
Yunyi Wu, Yanchun Li, Yan Gao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116132-116132
Open Access | Times Cited: 8
Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia
Xia Wu, Fangfang Wang, Xijing Yang, et al.
Small (2024) Vol. 20, Iss. 42
Closed Access | Times Cited: 7
IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells
Yi Zhang, Miso Park, Lucy Ghoda, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Circulating plasma exosomal long non-coding RNAs LINC00265, LINC00467, UCA1, and SNHG1 as biomarkers for diagnosis and treatment monitoring of acute myeloid leukemia
Qiaoling Xiao, Can Lin, Meixi Peng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 26
Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trials
Yang Xu, Ping Li, Yang Liu, et al.
Cancer Communications (2022) Vol. 42, Iss. 6, pp. 493-516
Open Access | Times Cited: 25
Application of iron oxide nanoparticles in the diagnosis and treatment of leukemia
Yiling Wang, Yan Yang, Xi Zheng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Development and validation of a cuproptosis-related prognostic model for acute myeloid leukemia patients using machine learning with stacking
Xichao Wang, Hao Sun, Yongfei Dong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Combinations of HDAC inhibitor and PPAR agonist induce ferroptosis of leukemic stem cell-like cells in acute myeloid leukemia
Hui Zhou, Dongmei Qin, Chendi Xie, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 23, pp. 5430-5444
Closed Access | Times Cited: 6
A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia
Pian Li, Junjun Li, Feng Wen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Assessment of the structure-activity relationship and antileukemic activity of diacylpyramide compounds as human ClpP agonists
Ranran Zhang, Pengyu Wang, Bingyan Wei, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115577-115577
Closed Access | Times Cited: 12
Rational discovery of dual FLT3/HDAC inhibitors as a potential AML therapy
Zhijie Wang, Donglin Wu, Xiaofei Zhao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115759-115759
Closed Access | Times Cited: 12
A global bibliometric and visualized analysis of the links between the autophagy and acute myeloid leukemia
Yao Gao, Zhenhui Wu, Yingfan Chen, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top